Rothschild Investment LLC Harrow Health, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q3 2024
A detailed history of Rothschild Investment LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 40 shares of HROW stock, worth $2,100. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 15
166.67%
Holding current value
$2,100
Previous $313,000
474.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
138Shares Held
20.3MCall Options Held
700KPut Options Held
564K-
Opaleye Management Inc. Boston, MA3.99MShares$210 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$143 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$96.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$37.7 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.42B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...